Librexia

Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
BioPharma Dive
Thu, 03/2/23 - 10:41 pm
Bristol Myers Squibb
JNJ
clinical trials
Librexia
bloodthinners